GO:0061690 lipoamidase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0061690 lipoamidase activity is a molecular function that removes the lipoyl group from lipoylated proteins, reversing protein lipoylation [1,3].
• Sirtuin 4 (SIRT4) is the best-characterized mammalian lipoamidase, directly regulating pyruvate dehydrogenase complex (PDC) activity.
• In bacteria, sirtuin lipoamidase activity is conserved and controls metabolic enzyme complexes such as PDC and KGDH.
• Human serum lipoamidase activity is largely due to biotinidase, linking lipoamidase function to biotin metabolism [4,7].
• Lipoamidase activity can be measured using fluorescent substrates like dansyl-α-lipoyllysine, enabling tissue-level analysis.
• Dysregulation of lipoamidase activity has implications for metabolic disorders, cancer, and neurological diseases [3,8].
Description
Lipoamidase activity (GO:0061690) is a molecular function that catalyzes the hydrolysis of the lipoyl group from lipoylated proteins, releasing (R)-lipoate and a lysyl residue on the target protein [1,3]. This activity is essential for maintaining the dynamic balance of protein lipoylation, a post-translational modification that regulates key metabolic enzymes such as the pyruvate dehydrogenase complex (PDC) and α-ketoglutarate dehydrogenase complex (KGDH) [1,3]. The reversible nature of lipoylation, mediated by lipoamidases, allows cells to rapidly adjust metabolic flux in response to changing energy demands. Researchers study lipoamidase activity because it directly impacts central carbon metabolism, mitochondrial function, and cellular signaling [3,8]. In mammals, SIRT4 is a mitochondrial sirtuin that functions as a lipoamidase, downregulating PDC activity and thereby influencing glucose oxidation and lipid synthesis. In bacteria, sirtuin lipoamidase activity is conserved and regulates metabolic enzyme complexes, highlighting its evolutionary importance. Beyond sirtuins, human serum lipoamidase activity has been attributed to biotinidase, suggesting overlapping substrate specificities among hydrolases [4,7]. Understanding lipoamidase activity is critical for deciphering how cells coordinate energy metabolism and for developing therapeutic strategies targeting metabolic diseases and cancer [3,8]. This article provides a comprehensive overview of the GO:0061690 term, its mechanism, key genes, disease relevance, and experimental approaches for studying it.
lipoamidase activity At A Glance
| GO ID | GO:0061690 |
|---|---|
| GO term | lipoamidase activity |
| Ontology | molecular_function |
| Synonym | lipoyl-X-hydrolase |
| Major function | Hydrolysis of lipoyl groups from lipoylated proteins, regulating metabolic enzyme complexes [1,3] |
| Reaction | H2O + N(6)-[(R)-lipoyl]-L-lysyl-[lipoyl-carrier protein] = (R)-lipoate + L-lysyl-[lipoyl-carrier protein] |
| Key enzymes | SIRT4 in mammals; bacterial sirtuins; biotinidase in human serum [1,3,4] |
| Subcellular location | Mitochondrial matrix (for SIRT4); serum (for biotinidase) [3,4] |
| Related diseases | Metabolic disorders, cancer, neurological diseases [3,8] |
What Is GO:0061690?
Lipoamidase activity (GO:0061690) is defined as the catalysis of the reaction: H2O + N(6)-[(R)-lipoyl]-L-lysyl-[lipoyl-carrier protein] = (R)-lipoate + L-lysyl-[lipoyl-carrier protein]. In other words, it is an enzymatic activity that removes a lipoyl group from a lipoylated lysine residue on a carrier protein, effectively reversing protein lipoylation [1,3]. This hydrolase activity is also known by the synonym lipoyl-X-hydrolase [QuickGO].
Why Is lipoamidase activity Important in Cell Biology?
Lipoamidase activity is crucial for regulating protein lipoylation, a modification that controls the activity of key metabolic enzymes such as pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase (KGDH) [1,3]. By removing lipoyl groups, lipoamidases like SIRT4 modulate metabolic flux, influencing glucose oxidation, lipid metabolism, and mitochondrial function. This regulation is vital for cellular adaptation to nutritional and energetic stress, and its dysregulation has been linked to metabolic diseases, cancer, and neurodegeneration [3,8].
• Regulates pyruvate dehydrogenase complex (PDC) activity, a gatekeeper of glucose oxidation.
• Controls α-ketoglutarate dehydrogenase complex (KGDH) and other metabolic enzyme complexes in bacteria.
• Modulates mitochondrial metabolism and energy homeostasis.
• Influences cancer cell metabolism by altering PDC activity.
• Linked to biotin metabolism through biotinidase's lipoamidase activity in serum [4,7].
• Provides a mechanism for dynamic reversibility of protein lipoylation [1,3].
• Potential therapeutic target for metabolic disorders and cancer [3,8].
• Enables cross-talk between sirtuin signaling and metabolic regulation.
• Important for understanding bacterial metabolic regulation and pathogenesis.
• Measurable with fluorescent substrates for diagnostic and research applications.
Mechanism, Genes and Research Methods
Substrate Recognition and Binding
In simple terms: The enzyme first grabs onto the lipoylated protein target.
Lipoamidases recognize and bind to lipoylated proteins, specifically interacting with the lipoyl-lysine moiety on carrier proteins such as the E2 subunits of PDC and KGDH [1,3]. This binding is mediated by structural elements that accommodate the lipoyl group, as demonstrated for SIRT4 and bacterial sirtuins [1,3].
Catalytic Hydrolysis
In simple terms: The enzyme then cuts the bond between the lipoyl group and the protein, releasing free lipoate.
The catalytic mechanism involves hydrolysis of the amide bond between the lipoyl group and the lysine residue, yielding free (R)-lipoate and a de-lipoylated protein [1,3]. This reaction is dependent on water and is characteristic of hydrolase activity [QuickGO]. SIRT4 catalyzes this reaction using NAD+ as a cofactor, although the exact mechanism remains under investigation.
Product Release and Recycling
In simple terms: After cutting, the enzyme releases the free lipoate and the modified protein, which can be re-lipoylated later.
Following hydrolysis, the released lipoate can be recycled for de novo lipoylation, while the de-lipoylated protein may be re-lipoylated by lipoyl ligases [1,3]. This dynamic cycle allows cells to rapidly adjust the lipoylation status of metabolic enzymes in response to metabolic cues.
Regulation by Sirtuins
In simple terms: Sirtuin enzymes like SIRT4 control this process in response to cellular energy levels.
SIRT4 is a mitochondrial sirtuin whose lipoamidase activity is regulated by NAD+ availability, linking its function to cellular energy status. In bacteria, sirtuin lipoamidases are conserved and regulate metabolic enzyme complexes, suggesting a broader regulatory role.
Biotinidase as a Serum Lipoamidase
In simple terms: In human blood, an enzyme called biotinidase also has lipoamidase activity.
Human serum lipoamidase activity is primarily due to biotinidase, which hydrolyzes lipoyl-lysine substrates [4,7]. This dual activity suggests that biotinidase may play a role in lipoate metabolism in circulation [4,7].
Key Genes Involved in GO:0061690 lipoamidase activity
The following genes and proteins are directly implicated in lipoamidase activity or its regulation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SIRT4 | Mitochondrial lipoamidase that de-lipoylates PDC and KGDH | Key regulator of metabolic flux and mitochondrial function |
| PDHA1 | E1 alpha subunit of PDC; lipoylation target of SIRT4 | Mutations cause pyruvate dehydrogenase deficiency |
| DLAT | E2 subunit of PDC; carries lipoyl groups | Target of lipoamidase activity; regulates PDC |
| DLD | Dihydrolipoamide dehydrogenase; component of PDC and KGDH | Lipoylation status affects enzyme complex activity |
| OGDH | E1 subunit of KGDH; lipoylation target | Regulated by lipoamidases in bacteria |
| DLST | E2 subunit of KGDH; carries lipoyl groups | Target of bacterial sirtuin lipoamidases |
| LIPT1 | Lipoyltransferase 1; attaches lipoate to proteins | Opposes lipoamidase activity; maintains lipoylation |
| LIPT2 | Lipoyltransferase 2; involved in lipoate synthesis | Indirectly affects lipoamidase substrates |
| LIAS | Lipoyl synthase; synthesizes lipoate | Provides substrate for lipoylation and lipoamidase |
| BTD | Biotinidase; exhibits lipoamidase activity in serum [4,7] | Deficiency causes biotinidase deficiency; affects lipoate metabolism [4,7] |
| SIRT1 | NAD+-dependent deacetylase; may interact with lipoylation pathways | Potential crosstalk with SIRT4 in metabolism |
| SIRT3 | Mitochondrial deacetylase; regulates metabolic enzymes | May modulate lipoylation indirectly |
| SIRT5 | Mitochondrial desuccinylase; involved in metabolic regulation | Potential interplay with lipoamidase activity |
| PDHX | E3-binding protein of PDC; structural component | Affects PDC assembly and lipoylation |
| PDHB | E1 beta subunit of PDC | Mutations affect PDC function |
| GCSH | Glycine cleavage system H protein; lipoylated | Target of lipoamidases in bacteria |
| DLD | Dihydrolipoamide dehydrogenase; shared by PDC and KGDH | Lipoylation-dependent activity |
How Is lipoamidase activity Regulated?
Lipoamidase activity is regulated at multiple levels. SIRT4, the primary mammalian lipoamidase, is transcriptionally regulated and its activity depends on NAD+ availability, linking it to cellular energy status. In bacteria, sirtuin lipoamidases are conserved and their expression is likely controlled by metabolic cues. Additionally, biotinidase's lipoamidase activity in serum may be influenced by nutritional and hormonal factors [4,7]. Post-translational modifications of lipoamidases themselves could also modulate their activity, though this remains less explored.
lipoamidase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SIRT4 | Metabolic disorders, cancer | SIRT4 knockout and overexpression cell lines |
| PDHA1 | Pyruvate dehydrogenase deficiency | Patient-derived fibroblasts with PDHA1 mutations |
| BTD | Biotinidase deficiency | BTD knockout HEK293 cells [4,7] |
| DLAT | PDC deficiency, neurological disorders | DLAT mutant knock-in cells |
| LIAS | Lipoic acid biosynthesis defects | LIAS knockout models |
Metabolic Disorders
Dysregulation of lipoamidase activity can lead to altered PDC and KGDH function, contributing to metabolic disorders such as pyruvate dehydrogenase deficiency and mitochondrial diseases. SIRT4-mediated de-lipoylation of PDC reduces glucose oxidation, and its overexpression has been linked to insulin resistance and obesity in some studies.
Cancer
SIRT4 is downregulated in several cancers, and its lipoamidase activity may suppress tumorigenesis by inhibiting PDC and altering metabolic flux. Loss of SIRT4 leads to increased PDC activity and enhanced proliferation, suggesting a tumor-suppressive role.
Neurological Diseases
Proper regulation of lipoylation is critical for neuronal survival, and defects in lipoamidase activity could contribute to neurodegeneration through metabolic impairment [3,8]. Biotinidase deficiency, which affects lipoamidase activity in serum, can cause neurological symptoms if untreated [4,7].
From lipoamidase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SIRT4 lipoamidase activity regulate PDC in vivo? | SIRT4 knockout mouse model |
| What is the effect of a point mutation in SIRT4 catalytic domain? | SIRT4 point-mutant knock-in cells |
| Can we tag endogenous SIRT4 for localization studies? | SIRT4-GFP knock-in via CRISPR |
| What happens when SIRT4 is overexpressed in cancer cells? | SIRT4 overexpression lentiviral system |
| How does biotinidase lipoamidase activity affect serum lipoate levels? | BTD knockout cell lines [4,7] |
| What is the role of bacterial sirtuin lipoamidases in metabolism? | Bacterial sirtuin knockout strains |
How to Study the lipoamidase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescent substrate assay | Lipoamidase enzymatic activity | Tissue and serum samples |
| Western blot with anti-lipoic acid | Protein lipoylation levels | Cell lysates [1,3] |
| Seahorse XF analyzer | Mitochondrial respiration and glycolysis | Live cells |
| LC-MS/MS proteomics | Lipoylated protein identification and quantification | Global lipoylation analysis |
| Immunoprecipitation | Protein-protein interactions | SIRT4 interactome |
| CRISPR knockout screening | Genes affecting lipoamidase activity | Functional genomics |
| RNA-seq | Transcriptional changes upon lipoamidase modulation | Gene expression profiling |
Enzymatic Activity Assays
Lipoamidase activity can be measured using fluorescent substrates such as dansyl-α-lipoyllysine, which releases a fluorescent product upon hydrolysis. This method is suitable for tissue homogenates and purified enzymes.
Western Blotting for Lipoylation
Protein lipoylation status can be assessed by Western blot using anti-lipoic acid antibodies, allowing detection of changes in lipoylation upon modulation of lipoamidase activity [1,3].
Metabolic Flux Analysis
Seahorse extracellular flux analysis and isotope tracing can measure the impact of lipoamidase activity on PDC flux and mitochondrial respiration.
Proteomics and Mass Spectrometry
Mass spectrometry-based proteomics can identify lipoylated proteins and quantify changes in lipoylation stoichiometry following lipoamidase manipulation [1,3].
How CRISPR Can Be Used to Study GO:0061690 lipoamidase activity
Knockout
CRISPR knockout of SIRT4 or BTD can eliminate lipoamidase activity, allowing researchers to study its role in metabolic regulation and disease [3,4]. Knockout cell lines are valuable for assessing baseline lipoylation levels and PDC activity.
Point Mutation
Introducing point mutations in the catalytic domain of SIRT4 (e.g., H161Y) can abolish lipoamidase activity while preserving other functions, enabling precise dissection of its enzymatic role.
Knock-in
Knock-in of tagged SIRT4 (e.g., FLAG or GFP) allows for endogenous localization and interaction studies without overexpression artifacts.
Overexpression
Overexpression of SIRT4 or BTD via lentiviral vectors can enhance lipoamidase activity, useful for gain-of-function studies in cancer and metabolic models.
How EDITGENE Supports lipoamidase activity Research
Researchers studying lipoamidase activity-related genes often need to determine whether a candidate gene is causally involved in metabolic regulation, disease progression, or drug response. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for lipoamidase activity research.
Frequently Asked Questions About lipoamidase activity
What is lipoamidase activity?
Lipoamidase activity (GO:0061690) is the enzymatic removal of lipoyl groups from lipoylated proteins, reversing protein lipoylation [1,3].
What genes are involved in lipoamidase activity?
Key genes include SIRT4, which encodes a mitochondrial lipoamidase, and BTD, which encodes biotinidase with lipoamidase activity in serum [3,4].
Which enzyme has lipoamidase activity?
SIRT4 is the primary mammalian lipoamidase, while bacterial sirtuins and human biotinidase also exhibit this activity [1,3,4].
How is lipoamidase activity measured?
It can be measured using fluorescent substrates like dansyl-α-lipoyllysine or by assessing protein lipoylation via Western blot.
What is the role of SIRT4 in metabolism?
SIRT4 de-lipoylates and inhibits pyruvate dehydrogenase complex, reducing glucose oxidation and affecting lipid metabolism.
Is lipoamidase activity linked to disease?
Yes, dysregulation is associated with metabolic disorders, cancer, and neurological diseases [3,8].
What is the difference between lipoamidase and biotinidase?
Biotinidase is an enzyme that also possesses lipoamidase activity, and in human serum, lipoamidase activity is largely due to biotinidase [4,7].
Can lipoamidase activity be targeted therapeutically?
It is a potential target for metabolic diseases and cancer, though further research is needed.
What are the substrates of lipoamidase?
Lipoylated proteins, such as the E2 subunits of PDC and KGDH, serve as substrates [1,3].
How does lipoamidase activity affect mitochondrial function?
By regulating PDC and KGDH activity, lipoamidases influence mitochondrial respiration and energy production.
Conclusion
Lipoamidase activity (GO:0061690) is a critical molecular function that reverses protein lipoylation, thereby regulating key metabolic enzyme complexes such as PDC and KGDH [1,3]. SIRT4 is the best-characterized mammalian lipoamidase, linking NAD+ metabolism to mitochondrial function and disease. Understanding this activity offers insights into metabolic regulation and potential therapeutic avenues for cancer and metabolic disorders [3,8]. Continued research using CRISPR models and advanced biochemical assays will further elucidate its roles.
References
- 1. Rowland EA et al.. 2017. Sirtuin Lipoamidase Activity Is Conserved in Bacteria as a Regulator of Metabolic Enzyme Complexes.. mBio 8(5) PMID: 28900027
- 3. Mathias RA et al.. 2014. Sirtuin 4 is a lipoamidase regulating pyruvate dehydrogenase complex activity.. Cell 159(7):1615-25 PMID: 25525879
- 4. Garganta CL et al.. 1990. Lipoamidase activity in human serum is due to biotinidase.. Clin Chim Acta 189(3):313-25 PMID: 2225462
- 6. Motafakkerazad R et al.. 2011. Simple HPLC evaluation of lipoamidase activity in tissue using a newly synthesized fluorescent substrate, dansyl-α-lipoyllysine.. J Nutr Sci Vitaminol (Tokyo) 57(5):377-82 PMID: 22293216
- 7. Nilsson L et al.. 1992. Lipoamidase and biotinidase deficiency: evidence that lipoamidase and biotinidase are the same enzyme in human serum.. Eur J Clin Chem Clin Biochem 30(3):119-26 PMID: 1599976
- 8. Oizumi J et al.. 1990. Lipoamidase is a multiple hydrolase.. Biochem J 271(1):45-9 PMID: 2222421
